1 study found for:    22828645 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Long-term Persistence Study to Assess a Booster Dose of GSK Biologicals' Hib-MenC
Conditions: Haemophilus Influenzae Type b Disease;   Meningococcal Serogroup C Diseases
Interventions: Biological: Haemophilus influenzae type b- and meningococcal (vaccine);   Biological: Infanrix™ penta;   Biological: Infanrix™ hexa;   Biological: Engerix-B;   Biological: NeisVac-C™;   Biological: Infanrix™ IPV/HIB;   Biological: Meningitec™

Indicates status has not been verified in more than two years